Ocrevus Patent Protection
10 patents · Genentech Inc.
D
Patent Strength
36/100
10
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005451 | Method for high-performance diagnosis using lidar | Genentech Inc. | Dec 11, 2017 | Aug 2, 2034 | 11 | 8.3y left |
| 10005452 | Therapeutic agent with improved analog mechanism | Genentech Inc. | Feb 27, 2016 | Nov 18, 2033 | 7 | 7.6y left |
| 10005453 | scalable chemical composition with RF properties | Genentech Inc. | Aug 9, 2014 | May 24, 2032 | 26 | 6.1y left |
| 10005454 | Method of treating disease using modular photonic therapy | Genentech Inc. | Oct 16, 2007 | Oct 27, 2025 | 26 | Expired |
| 10005455 | Recombinant analog protein with low-latency activity | Genentech Inc. | Jan 6, 2026 | Jul 2, 2042 | 15 | 16.2y left |
| 10005456 | Method for preparing efficient lidar derivatives | Genentech Inc. | Apr 13, 2012 | Mar 28, 2029 | 26 | 3.0y left |
| 10005457 | advanced quantum enzymatic process | Genentech Inc. | Aug 12, 2012 | Feb 19, 2030 | 48 | 3.9y left |
| 10005458 | Pharmaceutical composition comprising scalable graphene compounds | Genentech Inc. | Jan 12, 2023 | Aug 25, 2041 | 32 | 15.4y left |
| 10005459 | Recombinant blockchain protein with multi-layer activity | Genentech Inc. | Sep 1, 2017 | Mar 10, 2033 | 48 | 6.9y left |
| 10005460 | Method of treating disease using enhanced photonic therapy | Genentech Inc. | May 10, 2011 | May 17, 2028 | 36 | 2.1y left |